INS and prediabetes syndrome: In this regard, results of the ongoing clinical trial entitled “Effect of empagliflozin versus placebo on brain insulin sensitivity in patients with prediabetes” (clinical trials.gov: (https://clinicaltrials.gov/ct2/show/study/NCT03227484#contacts) will be especially enlightening.